文献速递脑血管病

近期卒中后依赖他人日常帮助的心房颤动患者口服抗凝药效果

Oral Anticoagulants in Atrial Fibrillation Patients With Recent Stroke Who Are Dependent on the Daily Help of Others.
PubMed 文献 · Stroke · 2021-07-27

基于巴塞尔观察性注册研究,分析801例心房颤动合并近期卒中患者,49%出院时依赖他人日常帮助(改良Rankin量表3-5分)。直接口服抗凝药(DOAC)较维生素K拮抗剂(VKA)降低复合结局风险(HR 0.58),依赖患者中DOAC获益与独立患者无显著交互作用。结论认为DOAC获益在依赖患者中得以维持。

要点

  • 出院时依赖他人日常帮助的房颤卒中患者,DOAC较VKA降低复合结局风险。
  • DOAC与VKA的疗效在依赖与独立患者间无显著交互作用。
  • 依赖患者中DOAC的获益与总体人群一致,支持此类患者使用DOAC。

核心结论

  • 在近期房颤卒中的患者中,出院时依赖他人日常帮助者使用DOAC的获益与独立患者相似。

研究设计与样本

  • 基于瑞士巴塞尔前瞻性观察性注册研究(Novel-Oral-Anticoagulants-in-Ischemic-Stroke-Patients-longterm),纳入801例房颤卒中患者,比较DOAC与VKA的疗效与安全性。

主要发现

  • DOAC治疗者复合结局风险低于VKA治疗者(HR 0.58,95%CI 0.42-0.81)。
  • 独立患者较依赖患者复合结局风险更低(HR 0.54,95%CI 0.40-0.71)。
  • 简单模型中,依赖患者DOAC vs VKA的HR为0.68(95%CI 0.45-1.01),独立患者为0.44(95%CI 0.26-0.75),交互P=0.212。
  • 调整模型中,依赖患者HR 0.74(95%CI 0.49-1.11),独立患者HR 0.51(95%CI 0.30-0.87),交互P=0.284。
  • 加权模型中,依赖患者HR 0.79(95%CI 0.48-1.31),独立患者HR 0.46(95%CI 0.26-0.81),交互P=0.163。

临床怎么用

  • 对于出院时依赖他人日常帮助的房颤卒中患者,可考虑优先选用DOAC而非VKA进行抗凝治疗。

局限性

  • 本研究为观察性注册研究,可能存在未测量的混杂因素。
  • 依赖患者中DOAC与VKA的比较在调整和加权模型中置信区间较宽,需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Data on the effectiveness and safety of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) in patients with stroke attributable to atrial fibrillation (AF) who were dependent on the daily help of others at hospital discharge are scarce. METHODS: Based on prospectively obtained data from the observational Novel-Oral-Anticoagulants-in-Ischemic-Stroke-Patients-longterm registry from Basel, Switzerland, we compared the occurrence of the primary outcome—the composite of recurrent ischemic stroke, major bleeding, and all-cause death—among consecutive patients with AF-stroke treated with either VKAs or DOACs between patients dependent (defined as modified Rankin Scale score, 3–5) and patients independent at discharge. We used simple, adjusted, and weighted Cox proportional hazards regression to account for potential confounders. RESULTS: We analyzed 801 patients (median age 80 years, 46% female), of whom 391 (49%) were dependent at discharge and 680 (85%) received DOACs. Over a total follow-up of 1216 patient-years, DOAC- compared to VKA-treated patients had a lower hazard for the composite outcome (hazard ratio [HR], 0.58 [95% CI, 0.42–0.81]), as did independent compared to dependent patients (HR, 0.54 [95% CI, 0.40–0.71]). There was no evidence that the effect of anticoagulant type (DOAC versus VKA) on the hazard for the composite outcome differed between dependent (HRdependent, 0.68 [95% CI, 0.45–1.01]) and independent patients (HRindependent, 0.44 [95% CI, 0.26–0.75]) in the simple model (Pinteraction=0.212). Adjusted (HRdependent, 0.74 [95% CI, 0.49–1.11] and HRindependent, 0.51 [95% CI, 0.30–0.87]; Pinteraction=0.284) and weighted models (HRdependent, 0.79 [95% CI, 0.48–1.31] and HRindependent, 0.46 [95% CI, 0.26–0.81]; Pinteraction=0.163) yielded concordant results. Secondary analyses focusing on the individual components of the composite outcome were consistent to the primary analyses. CONCLUSIONS: The benefits of DOACs in patients with atrial fibrillation with a recent stroke were maintained among patients who were dependent on the help of others at discharge. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03826927.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Meya L, Polymeris AA, Schaedelin S, et al. Oral Anticoagulants in Atrial Fibrillation Patients With Recent Stroke Who Are Dependent on the Daily Help of Others. Stroke. 2021. PMID: 34311567. doi:10.1161/STROKEAHA.120.033862

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。